Anne-marie Wenthzel
Vice President Business Development
Molecular Biology
SPRINT BIOSCIENCE
Sweden
Biography
Anne-Marie Wenthzel is the Vice President of Business Development at Sprint Bioscience, a drug development company listed at First North Premier. She has a science background from the field of diabetes. With a strong sales and marketing background, Anne-Marie joined Sprint Bioscience in 2011. She has been responsible for building the business development and been instrumental in two multimillion-dollar deals with Bayer, Germany and Petra Pharma, US.
Research Interest
Internal medicine
